Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TTRXTurn Therapeutics Inc.

Nasdaq · CIK 0002023016
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts168

Identity from submissions API

NameTurn Therapeutics Inc.
CIK0002023016
TickersTTRX
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN320456090
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone8185644011
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Global Health Solutions, Inc (2024-05-22T04:00:00.000Z → 2025-09-30T04:00:00.000Z)
Business address
250 NORTH WESTLAKE BLVD.
#210
WESTLAKE VILLAGE
CA
91362
CA
Mailing address
250
N. WESTLAKE BLVD.
WESTLAKE VILLAGE
CA
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

131 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003557 333-299915 261563863 33 1848
2026-11-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003556 333-299914 261563862 33 1848
2026-11-16 424B5 PROSPECTUS 0001213900-26-120739 333-299915 261562067 33 683506
2026-11-16 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-120692 333-299914 261561507 33 320754
2026-11-10 8-K CURRENT REPORT 7.01,9.01 0001213900-26-117781 001-42875 261538051 34 36787485 1 1
2026-11-09 S-3 REGISTRATION STATEMENT 0001213900-26-117232 333-299915 261533912 33 1546596 1 1
2026-11-09 S-3 REGISTRATION STATEMENT 0001213900-26-117224 333-299914 261533884 33 612479 1 1
2026-11-09 10-Q QUARTERLY REPORT 0001213900-26-117186 001-42875 261533764 34 5486985 1 1
2026-11-09 8-K CURRENT REPORT 2.02,9.01 0001213900-26-117180 001-42875 261533743 34 259804 1 1
2026-10-19 ARS ARS 0001213900-26-110683 001-42875 261469187 34 615049
2026-10-19 DEF 14A PROXY STATEMENT 0001213900-26-110670 001-42875 261469057 34 6130188 1 1
2026-10-07 8-K CURRENT REPORT 7.01,9.01 0001213900-26-107329 001-42875 261445161 34 23710630 1 1
2026-09-10 8-K CURRENT REPORT 7.01,9.01 0001213900-26-098584 001-42875 261369686 34 213242 1 1
2026-09-09 8-K CURRENT REPORT 7.01,9.01 0001213900-26-098224 001-42875 261366733 34 215796 1 1
2026-08-26 D xslFormDX01/primary_doc.xml 06b 0002023016-26-000001 021-595490 261323574 33 11166
2026-08-18 8-K CURRENT REPORT 3.02 0001213900-26-091002 001-42875 261288502 34 190249 1 1
2026-08-17 8-K CURRENT REPORT 7.01,9.01 0001213900-26-090766 001-42875 261286816 34 203678 1 1
2026-08-12 10-Q QUARTERLY REPORT 0001213900-26-088427 001-42875 261268352 34 4931850 1 1
2026-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-26-088411 001-42875 261268182 34 248451 1 1
2026-07-28 8-K CURRENT REPORT 7.01,9.01 0001213900-26-081996 001-42875 261207568 34 24225497 1 1
2026-07-07 8-K CURRENT REPORT 7.01,9.01 0001213900-26-075757 001-42875 261157849 34 14175051 1 1
2026-06-08 4 xslF345X06/ownership.xml 0001213900-26-066395 5816
2026-06-08 4 xslF345X06/ownership.xml 0001213900-26-066394 5806
2026-06-08 4 xslF345X06/ownership.xml 0001213900-26-066393 5761
2026-06-08 4 xslF345X06/ownership.xml 0001213900-26-066391 5804
2026-06-03 8-K CURRENT REPORT 7.01,9.01 0001213900-26-064405 001-42875 261058823 34 26166837 1 1
2026-06-01 4 xslF345X06/ownership.xml 0001213900-26-063629 13212
2026-06-01 8-K CURRENT REPORT 7.01,9.01 0001213900-26-063177 001-42875 261047495 34 298570 1 1
2026-05-27 8-K CURRENT REPORT 7.01,9.01 0001213900-26-061244 001-42875 261022217 34 226690 1 1
2026-05-19 8-K CURRENT REPORT 7.01,9.01 0001213900-26-058730 001-42875 26995948 34 220273 1 1
2026-05-18 8-K CURRENT REPORT 7.01,9.01 0001213900-26-058140 001-42875 26990855 34 216337 1 1
2026-05-13 C-TR xslC_X01/primary_doc.xml 0001213900-26-055361 020-34168 26970613 33 4792
2026-05-11 10-Q QUARTERLY REPORT 0001213900-26-054490 001-42875 26963471 34 4462698 1 1
2026-05-11 8-K CURRENT REPORT 2.02,9.01 0001213900-26-054480 001-42875 26963285 34 246116 1 1
2026-04-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-040158 005-95596 26839611 34 6757
2026-04-03 4 xslF345X06/ownership.xml 0001213900-26-039715 7224
2026-04-03 4 xslF345X06/ownership.xml 0001213900-26-039714 4775
2026-04-03 4 xslF345X06/ownership.xml 0001213900-26-039713 7650
2026-04-03 4 xslF345X06/ownership.xml 0001213900-26-039712 5936
2026-04-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001065 333-290800 26836693 33 1880
2026-04-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001062 333-289972 26836689 33 1880
2026-03-31 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-26-037583 333-290800 26823125 33 445904
2026-03-31 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-26-037561 333-289972 26822991 33 433987
2026-03-31 10-K ANNUAL REPORT 0001213900-26-037505 001-42875 26822533 34 6811441 1 1
2026-03-31 8-K CURRENT REPORT 2.02,9.01 0001213900-26-037470 001-42875 26822180 34 229436 1 1
2026-03-24 8-K CURRENT REPORT 1.01,2.03,3.02,7.01,9.01 0001213900-26-033233 001-42875 26784257 34 798059 1 1
2026-02-17 8-K CURRENT REPORT 7.01,9.01 0001213900-26-016916 001-42875 26636576 34 212906 1 1
2026-02-09 8-K CURRENT REPORT 7.01,9.01 0001213900-26-013490 001-42875 26609741 34 57133865 1 1
2026-02-04 4 xslF345X05/ownership.xml 0001213900-26-011817 5255
2026-02-04 3 xslF345X02/ownership.xml 0001213900-26-011816 15651
2026-01-12 8-K CURRENT REPORT 7.01,9.01 0001213900-26-003153 001-42875 26524775 34 218522 1 1
2026-01-07 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-26-002173 001-42875 26515920 34 38101975 1 1
2025-12-12 4 xslF345X05/ownership.xml 0001213900-25-121326 4763
2025-11-25 4 xslF345X05/ownership.xml 0001213900-25-114990 5685
2025-11-24 4 xslF345X05/ownership.xml 0001213900-25-113841 5686
2025-11-21 4 xslF345X05/ownership.xml 0001213900-25-113723 6240
2025-11-17 4 xslF345X05/ownership.xml 0001213900-25-111713 5364
2025-11-17 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-111523 333-290800 251491119 33 482954
2025-11-17 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-111520 333-289972 251491079 33 470970
2025-11-13 10-Q QUARTERLY REPORT 0001213900-25-109586 001-42875 251475521 34 3923531 1 1
2025-11-13 8-K CURRENT REPORT 2.02,9.01 0001213900-25-109580 001-42875 251475489 34 238598 1 1
2025-11-12 8-K CURRENT REPORT 7.01,9.01 0001213900-25-108655 001-42875 251468754 34 213967 1 1
2025-11-04 8-K CURRENT REPORT 7.01,9.01 0001213900-25-106265 001-42875 251450864 34 200930 1 1
2025-10-30 8-K FORM 8-K 7.01,9.01 0001104659-25-104028 001-42875 251432255 34 215299 1 1
2025-10-29 4 OWNERSHIP DOCUMENT 0001104659-25-103894 5252
2025-10-29 424B5 424B5 0001104659-25-103384 333-290800 251426639 33 2373899
2025-10-28 8-K FORM 8-K 1.01,9.01 0001104659-25-103160 001-42875 251424805 34 272365 1 1
2025-10-23 4 OWNERSHIP DOCUMENT 0001104659-25-101924 4802
2025-10-23 4 OWNERSHIP DOCUMENT 0001104659-25-101923 5158
2025-10-22 8-K FORM 8-K 7.01,9.01 0001104659-25-101410 001-42875 251408638 34 226647 1 1
2025-10-10 4 OWNERSHIP DOCUMENT 0001104659-25-098571 5280
2025-10-10 4 OWNERSHIP DOCUMENT 0001104659-25-098570 5250
2025-10-10 4 OWNERSHIP DOCUMENT 0001104659-25-098569 5899
2025-10-10 4 OWNERSHIP DOCUMENT 0001104659-25-098568 5207
2025-10-10 4 OWNERSHIP DOCUMENT 0001104659-25-098567 5252
2025-10-09 S-1 S-1 0001104659-25-098363 333-290800 251385256 33 2803122 1 1
2025-10-08 424B4 424B4 0001104659-25-097840 333-289972 251381676 33 2465690
2025-10-07 3 OWNERSHIP DOCUMENT 0001104659-25-097624 12419
2025-10-07 3 OWNERSHIP DOCUMENT 0001104659-25-097623 13304
2025-10-07 3 OWNERSHIP DOCUMENT 0001104659-25-097622 14374
2025-10-07 3 OWNERSHIP DOCUMENT 0001104659-25-097621 14740
2025-10-07 3 OWNERSHIP DOCUMENT 0001104659-25-097620 12579
2025-10-07 3 OWNERSHIP DOCUMENT 0001104659-25-097617 14428
2025-10-07 S-8 FORM S-8 0001104659-25-097589 333-290762 251380735 33 227468 1 1
2025-10-07 CERT 8A_Cert_TTRX_2023016.pdf 0001354457-25-000999 001-42875 251379594 34 125039
2025-10-07 8-A12B/A 8-A12B/A 0001104659-25-097446 001-42875 251379206 34 15074
2025-10-02 8-K FORM 8-K 1.01,3.03,5.02,5.03,9.01 0001104659-25-096003 001-42875 251368120 34 895107 1 1
2025-09-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003218 333-289972 251362343 33 1775
2025-09-29 8-A12B 8-A12B 0001104659-25-094385 001-42875 251355001 34 14058
2025-09-26 CORRESP filename1.htm 0001104659-25-093642 5974
2025-09-24 CORRESP filename1.htm 0001104659-25-092997 14610
2025-09-24 S-1/A S-1/A 0001104659-25-092994 333-289972 251339582 33 2754212 1 1
2025-09-23 UPLOAD filename1.pdf 0000000000-25-010348 377-08130 43001
2025-09-22 1-SA 1-SA 0001104659-25-092035 24R-00996 251329412 33 338997
2025-09-16 CORRESP filename1.htm 0001104659-25-090476 20878
2025-09-16 S-1/A S-1/A 0001104659-25-090474 333-289972 251318059 33 3107789 1 1
2025-09-11 UPLOAD filename1.pdf 0000000000-25-009891 377-08130 46085
2025-09-03 DRS filename1.htm 0001104659-25-086552 377-08408 251287342 33 2539002
2025-09-02 S-1 S-1 0001104659-25-085850 333-289972 251282597 33 4305388 1 1
2025-08-29 CORRESP filename1.htm 0001104659-25-085851 41167
2025-08-14 UPLOAD filename1.pdf 0000000000-25-008603 377-08130 55373
2025-07-30 DRSLTR filename1.htm 0001104659-25-072241 104388
2025-07-30 DRS/A filename1.htm 0001104659-25-072227 377-08130 251168035 33 1969085
2025-06-27 1-K xsl1-K_X01/primary_doc.xml 0001104659-25-063517 24R-00996 251084463 33 417090
2025-06-20 DRS filename1.htm 0001104659-25-061163 377-08130 251061498 33 1902384
2025-06-13 253G2 253G2 0001104659-25-059385 024-12562 251046936 33 4800
2025-04-29 C-AR xslC_X01/primary_doc.xml 0001665160-25-000795 020-34168 25883574 33 28712085
2025-04-22 253G2 253G2 0001104659-25-037431 024-12562 25857858 33 4336
2025-04-02 253G2 253G2 0001104659-25-030828 024-12562 25801875 33 851377
2025-03-31 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-25-000062 024-12562 25796280 33 1772
2025-03-27 CORRESP filename1.htm 0001104659-25-028773 19458
2025-03-27 1-A/A xsl1-A_X01/primary_doc.xml 0001104659-25-028377 024-12562 25774999 33 967293
2025-03-26 1-A/A xsl1-A_X01/primary_doc.xml 0001104659-25-028175 024-12562 25772272 33 128603
2025-03-25 CORRESP filename1.htm 0001104659-25-027731 26734
2025-03-25 1-A/A xsl1-A_X01/primary_doc.xml 0001104659-25-027729 024-12562 25767889 33 892331
2025-03-25 C-U xslC_X01/primary_doc.xml 0001665160-25-000478 020-34945 25765366 33 10653
2025-03-24 UPLOAD filename1.pdf 0000000000-25-003121 024-12562 44012
2025-03-18 CORRESP filename1.htm 0001104659-25-025092 38340
2025-03-18 1-A/A xsl1-A_X01/primary_doc.xml 0001104659-25-025091 024-12562 25749225 33 890578
2025-03-17 UPLOAD filename1.pdf 0000000000-25-002905 024-12562 50061
2025-03-06 CORRESP filename1.htm 0001104659-25-021270 76537
2025-03-06 1-A/A xsl1-A_X01/primary_doc.xml 0001104659-25-021267 024-12562 25714350 33 886449
2025-02-27 UPLOAD filename1.pdf 0000000000-25-002230 024-12562 58482
2025-01-31 1-A xsl1-A_X01/primary_doc.xml 0001104659-25-007880 024-12562 25576974 33 1981931
2025-01-17 C/A xslC_X01/primary_doc.xml 0001665160-25-000078 020-34945 25538048 33 10195
2024-12-18 C/A xslC_X01/primary_doc.xml 0001665160-24-001854 020-34945 241558908 33 35856784
2024-11-12 C-U xslC_X01/primary_doc.xml 0001665160-24-001586 020-34168 241445102 33 10608
2024-10-22 C xslC_X01/primary_doc.xml 0001665160-24-001439 020-34945 241387081 33 27461472
2024-08-19 C/A xslC_X01/primary_doc.xml 0001665160-24-001198 020-34168 241219741 33 33067423
2024-07-15 C/A xslC_X01/primary_doc.xml 0001665160-24-001071 020-34168 241116430 33 36080577
2024-05-22 C xslC_X01/primary_doc.xml 0001665160-24-000890 020-34168 24972278 33 28272984

Latest XBRL company facts

One latest value per concept from companyfacts (168 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 30.57M 2026-11-06 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
dei EntityPublicFloat Entity Public Float USD 0 2024-06-30 2025 FY 10-K 2026-03-31 0001213900-26-037505
ffd NetFeeAmt NetFeeAmt USD 751.91 2026-11-06 S-3 2026-11-09 0001213900-26-117224
ffd TtlFeeAmt TtlFeeAmt USD 751.91 2026-11-06 S-3 2026-11-09 0001213900-26-117224
ffd TtlOfferingAmt TtlOfferingAmt USD 8.64M 2026-11-06 S-3 2026-11-09 0001213900-26-117224
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-06 S-3 2026-11-09 0001213900-26-117224
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-06 S-3 2026-11-09 0001213900-26-117224
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 2.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 41.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap AdjustmentForAmortization Amortization USD 43,663 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 162,865 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-109586
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 713,205 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 155,830 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001213900-26-054490
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 500,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001213900-26-054490
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 53,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap Assets Assets USD 16.35M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap AssetsCurrent Assets, Current USD 11.08M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 9.43M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 10.36M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations USD 5.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 10.40M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 9.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 5.03 2026-06-30 2026 Q2 10-Q 2026-08-12 0001213900-26-088427
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.19M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 1.19M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001213900-26-088427
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 6.63M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 30.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 30.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap CommonStockValue Common Stock, Value, Issued USD 3,053 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ContingentConsiderationClassifiedAsEquityFairValueDisclosure Contingent Consideration Classified as Equity, Fair Value Disclosure USD 150,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001213900-26-088427
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 1.44M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 1.44M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 2.00M 2026-03-23 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DebtConversionOriginalDebtInterestRateOfDebt Debt Conversion, Original Debt, Interest Rate of Debt pure 0.8 2026-03-23 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 7.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.08 2026-03-23 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DebtLongtermAndShorttermCombinedAmount Debt, Long-term and Short-term, Combined Amount USD 6.19M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 4.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 614,070 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 4.92M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD -1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 119,989 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 4.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 709 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 301,983 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 4.06M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 34,927 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 119,989 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 3.54M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 14.50M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 7.30M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 30,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 159,995 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 3.94M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 103,478 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 52,746 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 570,579 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.44 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.44 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001213900-26-054490
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.213 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 3.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 5.50M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001213900-26-088427
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD -257,530 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 602,528 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 57,337 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 57,337 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 57,337 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 57,337 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 57,337 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.18M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 889,213 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -5.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -511,184 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -7,977 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 912,673 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap InterestExpenseDebt Interest Expense, Debt USD 0.7 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 703,502 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap InterestExpenseOther Interest Expense, Other USD 0.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -223,219 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001213900-26-088427
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 364,437 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 223,057 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 86,909 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 51,669 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 35,240 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 6,533 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap Liabilities Liabilities USD 10.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 16.35M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.48M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LineOfCreditFacilityCommitmentFeePercentage Line of Credit Facility, Commitment Fee Percentage pure 0.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage pure 0.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LongTermDebt Long-term Debt USD 7.26M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 444,204 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 2.86M 2026-03-31 2026 Q1 10-Q 2026-05-11 0001213900-26-054490
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 2.86M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 3.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 5.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 9.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -34,165 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -4.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -13.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued shares 5.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -8.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001213900-26-054490
us-gaap OperatingExpenses Operating Expenses USD 4.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -4.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 80,376 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 46,345 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 34,081 2025-12-31 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap OperatingLeasePayments Operating Lease, Payments USD 49,920 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 44,722 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.09 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap OtherExpenses Other Expenses USD 2.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -5,578 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 34,165 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 103,451 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ProceedsFromCollectionOfAdvanceToAffiliate Proceeds from Collection of Advance to Affiliate USD 3.00M 2025-10-31 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 4.10M 2025-12-15 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ProfessionalFees Professional Fees USD 848,211 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -35.44M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 133,615 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap SecurityDeposit Security Deposit USD 8,582 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 463.92M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 3.00M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-109586
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 21.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.84M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.78 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 40,030 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 4.59 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 916,984 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 29.81M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.86M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.96 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap SharePrice Share Price USD/shares 5.03 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 4.95 2025-10-23 2026 Q1 10-Q 2026-05-11 0001213900-26-054490
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 5.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 1.07M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap StockIssued1 Stock Issued USD 850,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 342,857 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001213900-26-054490
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 250,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 777,792 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 8.88M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 1.19M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037505
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 29.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 29.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 1.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117186

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →